Skip to contentE
Escalon Medical Corp
E
ESMCEscalon Medical Corp Q2 2026 · 10-Q
Revenue$3.59M$3.59M+11.5% vs Q2 2025 Net Income$97.68K$97.68K−60.3% vs Q2 2025 EPS Diluted$0.01$0.01−50.0% vs Q2 2025 Operating Income$98,738−61.4% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Escalon Medical Corp · CIK 862668 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$517,415N/M Margins · derivedOperating margin2.7%−5.2 pt vs Q2 2025
Net margin2.7%−4.9 pt vs Q2 2025
ended Dec 31, 2025 · filed Feb 17, 2026 · 48 d after period end